Jelsing J, Vrang N, Hansen G, Ravn K, Tang-Christensen M, Knudsen LB
However, as discussed next, a bona fide indication for GLP-1 RAs to reduce the risk of developing HF or to treat chronic HF arguably requires the resolution of several unknowns
Introduction Type 2 diabetes mellitus (T2DM) constitutes one of the most widespread diseases with a prevalence of 536.6 million people in 2021 and an estimated increase to 783.2 million by 2045 [1]
Schedule a free consultation with a registered dietitian who can help you optimize your nutrition, manage side effects, and lose weight safely and effectively while using a GLP-1 medication, all at no cost to you
They can provide improved blood sugar regulation, assist with sustained weight loss, and might even reduce the risk for cardiovascular disease
a , Overview of representative interactions